Advertisement
Screener

Bausch Health Companies Inc. (BHC) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent

Bausch Health Companies Inc. Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent

Bausch Health Companies Inc. (BHC) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent · last filed 2024-10-31

  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2023-09-30 was $2.00M, a 100.00% increase year-over-year.
  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2023-06-30 was $0.00.
  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2023-03-31 was $0.00.
  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2015 was -$17.20M, a 125.71% decline from fiscal 2014.
  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2014 was $66.90M.
  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2013 was -$37.80M.
  • Bausch Health Companies Inc. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2012 was -$200.00K, a 136.70% decline from fiscal 2011.
Period endOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 monthOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month as first filedOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 monthOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month as first filedOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 monthOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month as first filedOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 monthOther Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 month as first filed
2024-09-30$0.00
10-Q · filed 2024-10-31
$0.00
10-Q · filed 2024-10-31
2023-09-30$2.00M
10-Q · filed 2024-10-31
$2.00M
derived: sum of 2 quarters · filed 2024-10-31
$2.00M
10-Q · filed 2024-10-31
2023-06-30$0.00
10-Q · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
2023-03-31$0.00
10-Q · filed 2023-05-04
2022-09-30$1.00M
10-Q · filed 2023-11-02
$0.00
derived: sum of 2 quarters · filed 2023-11-02
-$6.00M
10-Q · filed 2023-11-02
2022-06-30-$1.00M
10-Q · filed 2023-08-03
-$7.00M
10-Q · filed 2023-08-03
2022-03-31-$6.00M
10-Q · filed 2023-05-04
2021-09-30$1.00M
10-Q · filed 2022-11-03
$2.00M
derived: sum of 2 quarters · filed 2022-11-03
$1.00M
10-Q · filed 2022-11-03
2021-06-30$1.00M
10-Q · filed 2022-08-09
$0.00
10-Q · filed 2022-08-09
2021-03-31-$1.00M
10-Q · filed 2022-05-10
2020-09-30$1.00M
10-Q · filed 2021-11-02
-$3.00M
derived: sum of 2 quarters · filed 2021-11-02
$2.00M
10-Q · filed 2021-11-02
2020-06-30-$4.00M
10-Q · filed 2021-08-03
$1.00M
10-Q · filed 2021-08-03
2020-03-31$5.00M
10-Q · filed 2021-05-04
2019-09-30$0.00
10-Q · filed 2020-11-03
$1.00M
derived: sum of 2 quarters · filed 2020-11-03
$1.00M
10-Q · filed 2020-11-03
2019-06-30$1.00M
10-Q · filed 2020-08-06
$1.00M
10-Q · filed 2020-08-06
2019-03-31$0.00
10-Q · filed 2020-05-07
2018-09-30$1.00M
10-Q · filed 2019-11-04
$2.00M
derived: sum of 2 quarters · filed 2019-11-04
$2.00M
10-Q · filed 2019-11-04
2018-06-30$1.00M
10-Q · filed 2019-08-06
$1.00M
10-Q · filed 2019-08-06
2018-03-31$0.00
10-Q · filed 2019-05-06
2017-09-30$3.00M
10-Q · filed 2018-11-06
$3.00M
derived: sum of 2 quarters · filed 2018-11-06
$4.00M
10-Q · filed 2018-11-06
2017-06-30$0.00
10-Q · filed 2018-08-07
$1.00M
10-Q · filed 2018-08-07
2017-03-31$1.00M
10-Q · filed 2018-05-08
2016-09-30$1.00M
10-Q · filed 2017-11-07
$600.00K
10-Q · filed 2016-11-09
$1.00M
derived: sum of 2 quarters · filed 2017-11-07
$2.00M
10-Q · filed 2017-11-07
$1.60M
10-Q · filed 2016-11-09
-$16.60M
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30$0.00
10-Q · filed 2017-08-08
$600.00K
10-Q · filed 2016-08-09
$1.00M
10-Q · filed 2017-08-08
-$17.60M
derived: sum of 3 quarters · filed 2017-08-08
-$17.10M
derived: sum of 4 quarters · filed 2017-08-08
2016-03-31$1.00M
10-Q · filed 2017-05-09
$400.00K
10-Q · filed 2016-06-07
-$17.60M
derived: sum of 2 quarters · filed 2017-05-09
-$17.10M
derived: sum of 3 quarters · filed 2017-05-09
-$16.60M
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31-$18.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
-$18.10M
derived: sum of 2 quarters · filed 2016-11-09
-$17.60M
derived: sum of 3 quarters · filed 2016-11-09
-$17.20M
10-K · filed 2016-04-29
2015-09-30$500.00K
10-Q · filed 2016-11-09
$1.00M
derived: sum of 2 quarters · filed 2016-11-09
$1.40M
10-Q · filed 2016-11-09
$66.50M
derived: sum of 4 quarters · filed 2016-11-09
2015-06-30$500.00K
10-Q · filed 2016-08-09
$900.00K
10-Q · filed 2016-08-09
$66.00M
derived: sum of 3 quarters · filed 2016-08-09
$66.60M
derived: sum of 4 quarters · filed 2016-08-09
2015-03-31$400.00K
10-Q · filed 2016-06-07
$65.50M
derived: sum of 2 quarters · filed 2016-06-07
$66.10M
derived: sum of 3 quarters · filed 2016-06-07
$66.70M
derived: sum of 4 quarters · filed 2016-06-07
2014-12-31$65.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
$65.70M
derived: sum of 2 quarters · filed 2016-04-29
$66.30M
derived: sum of 3 quarters · filed 2016-04-29
$66.90M
10-K · filed 2016-04-29
2014-09-30$600.00K
10-Q · filed 2015-10-26
$1.20M
derived: sum of 2 quarters · filed 2015-10-26
$1.80M
10-Q · filed 2015-10-26
-$36.00M
derived: sum of 4 quarters · filed 2016-04-29
2014-06-30$600.00K
10-Q · filed 2015-07-28
$1.20M
10-Q · filed 2015-07-28
-$36.60M
derived: sum of 3 quarters · filed 2016-04-29
-$36.60M
derived: sum of 4 quarters · filed 2016-04-29
2014-03-31$600.00K
10-Q · filed 2015-04-30
-$37.20M
derived: sum of 2 quarters · filed 2016-04-29
-$37.20M
derived: sum of 3 quarters · filed 2016-04-29
-$37.20M
derived: sum of 4 quarters · filed 2016-04-29
2013-12-31-$37.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
-$37.80M
derived: sum of 2 quarters · filed 2016-04-29
-$37.80M
derived: sum of 3 quarters · filed 2016-04-29
-$37.80M
10-K · filed 2016-04-29
-$37.76M
10-K · filed 2014-02-28
2013-09-30$0.00
10-Q · filed 2014-10-24
$5.00K
10-Q · filed 2013-11-01
$0.00
derived: sum of 2 quarters · filed 2014-10-24
$0.00
10-Q · filed 2014-10-24
$4.00K
10-Q · filed 2013-11-01
-$1.00K
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30$0.00
10-Q · filed 2014-08-01
-$13.00K
10-Q · filed 2013-08-07
$0.00
10-Q · filed 2014-08-01
-$1.00K
10-Q · filed 2013-08-07
-$1.00K
derived: sum of 3 quarters · filed 2015-02-25
-$401.00K
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$0.00
10-Q · filed 2014-05-09
$12.00K
10-Q · filed 2013-05-03
-$1.00K
derived: sum of 2 quarters · filed 2015-02-25
-$401.00K
derived: sum of 3 quarters · filed 2015-02-25
-$323.00K
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
-$401.00K
derived: sum of 2 quarters · filed 2015-02-25
-$323.00K
derived: sum of 3 quarters · filed 2015-02-25
-$200.00K
10-K · filed 2015-02-25
-$259.00K
10-K · filed 2013-02-28
2012-09-30-$400.00K
10-Q · filed 2013-11-01
-$322.00K
derived: sum of 2 quarters · filed 2013-11-01
-$199.00K
10-Q · filed 2013-11-01
$1.12M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30$78.00K
10-Q · filed 2013-08-07
$201.00K
10-Q · filed 2013-08-07
$1.52M
derived: sum of 3 quarters · filed 2014-02-28
$1.64M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31$123.00K
10-Q · filed 2013-05-03
$1.45M
derived: sum of 2 quarters · filed 2014-02-28
$1.57M
derived: sum of 3 quarters · filed 2014-02-28
$1.67M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$1.44M
derived: sum of 2 quarters · filed 2014-02-28
$1.54M
derived: sum of 3 quarters · filed 2014-02-28
$545.00K
10-K · filed 2014-02-28
2011-09-30$121.00K
10-Q · filed 2012-11-05
$223.00K
derived: sum of 2 quarters · filed 2012-11-05
-$777.00K
10-Q · filed 2012-11-05
2011-06-30$102.00K
10-Q · filed 2012-08-03
-$898.00K
10-Q · filed 2012-08-03
2011-03-31-$1.00M
10-Q · filed 2012-05-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42